{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:49:54Z","timestamp":1793393394898,"version":"4.5.0"},"reference-count":48,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Helicobacter pylori (HP) is a Gram-negative bacterium which finds its suitable habitat in the stomach. The infection affects about half of the global population with high variability in prevalence among regions and for age. HP is the main causative agent of chronic active gastritis, peptic and duodenal ulcers, and may be the primary cause of gastric cancer or MALT lymphoma. Due to the high rate of failure of eradication therapy in various countries and the increase in antibiotic resistance reported in the literature, there is an ever wider need to seek alternative therapeutic treatments. Probiotics seem to be a promising solution. In particular, the Limosilactobacillus reuteri (L. reuteri) species is a Gram-positive bacterium and is commonly found in the microbiota of mammals. L. reuteri is able to survive the gastric acid environment and bile and to colonize the gastric mucosa. This species is able to inhibit the growth of several pathogenic bacteria through different mechanisms, keeping the homeostasis of the microbiota. In particular, it is able to secrete reuterin and reutericycline, substances that exhibit antimicrobial properties, among other molecules. Through the secretion of these and the formation of the biofilm, it has been found to strongly inhibit the growth of HP and, at higher concentrations, to kill it. Moreover, it reduces the expression of HP virulence factors. In clinical trials, L. reuteri has been shown to decrease HP load when used as a single treatment, but has not achieved statistical significance in curing infected patients. As an adjuvant of standard regimens with antibiotics and pump inhibitors, L. reuteri can be used not only to improve cure rates, but especially to decrease gastrointestinal symptoms, which are a common cause of lack of compliance and interruption of therapy, leading to new antibiotic resistance.<\/jats:p>","DOI":"10.3390\/medicina57070733","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T11:26:10Z","timestamp":1626780370000},"page":"733","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection"],"prefix":"10.3390","volume":"57","author":[{"given":"Costantino","family":"Dargenio","sequence":"first","affiliation":[{"name":"Interdisciplinary Department of Medicine, Pediatric Section, University of Bari, Children\u2019s Hospital \u201cGiovanni XXIII\u201d, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Nadia","family":"Dargenio","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, Pediatric Section, University of Bari, Children\u2019s Hospital \u201cGiovanni XXIII\u201d, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bizzoco","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, Pediatric Section, University of Bari, Children\u2019s Hospital \u201cGiovanni XXIII\u201d, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Indrio","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Pediatric Section, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4603-974X","authenticated-orcid":false,"given":"Ruggiero","family":"Francavilla","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, Pediatric Section, University of Bari, Children\u2019s Hospital \u201cGiovanni XXIII\u201d, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Cristofori","sequence":"additional","affiliation":[{"name":"Interdisciplinary Department of Medicine, Pediatric Section, University of Bari, Children\u2019s Hospital \u201cGiovanni XXIII\u201d, 70126 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fonc.2019.00075","article-title":"The Possible Role of Helicobacter pylori in Gastric Cancer and Its Management","volume":"9","author":"Alfarouk","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00392-019-01418-w","article-title":"Association between atrial fibrillation and Helicobacter pylori","volume":"108","author":"Tetta","year":"2019","journal-title":"Clin. Res. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/apt.14561","article-title":"Systematic review with meta-analysis: The worldwide prevalence of Helicobacter pylori infection","volume":"47","author":"Zamani","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Nocturne, G., Pontarini, E., Bombardieri, M., and Mariette, X. (2019). Lymphomas complicating primary Sj\u00f6gren\u2019s syndrome: From autoimmunity to lymphoma. Rheumatology, kez052.","DOI":"10.1093\/rheumatology\/kez052"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.12659\/AJCR.902843","article-title":"Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Colon: A Case Report and a Literature Review","volume":"18","author":"Abbas","year":"2017","journal-title":"Am. J. Case Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3748\/wjg.v21.i13.3773","article-title":"Helicobacter pylorieradication in gastric diffuse large B cell lymphoma","volume":"21","author":"Paydas","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-147-8-200710160-00008","article-title":"Meta-analysis: Duration of First-Line Proton-Pump Inhibitor\u2013Based Triple Therapy for Helicobacter pylori Eradication","volume":"147","author":"Fuccio","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","article-title":"Meta-analysis: The effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy","volume":"25","author":"Tong","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pyloriinfection\u2014The Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2016","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1093\/cid\/civ085","article-title":"Risk and Safety of Probiotics","volume":"60","author":"Doron","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1093\/femsre\/fux030","article-title":"Lifestyles in transition: Evolution and natural history of the genus Lactobacillus","volume":"41","author":"Duar","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/MMBR.67.3.429-453.2003","article-title":"Surviving the Acid Test: Responses of Gram-Positive Bacteria to Low pH","volume":"67","author":"Cotter","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1128\/AAC.32.12.1854","article-title":"Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri","volume":"32","author":"Talarico","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/AAC.33.5.674","article-title":"Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri","volume":"33","author":"Talarico","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12602-017-9342-2","article-title":"In Vitro Antimicrobial Activity and Downregulation of Virulence Gene Expression on Helicobacter pylori by Reuterin","volume":"10","year":"2018","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.carbpol.2015.12.037","article-title":"Exopolysaccharides of Lactobacillus reuteri: Their influence on adherence of E. coli to epithelial cells and inflammatory response","volume":"141","author":"Pulzova","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Puca, V., Ercolino, E., Celia, C., Bologna, G., Di Marzio, L., Mincione, G., Marchisio, M., Miscia, S., Muraro, R., and Lanuti, P. (2019). Detection and Quantification of eDNA-Associated Bacterial Membrane Vesicles by Flow Cytometry. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215307"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3389\/fmicb.2017.01040","article-title":"Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938","volume":"8","author":"Grande","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Al-Hadidi, A., Navarro, J., Goodman, S., Bailey, M., and Besner, G. (2021). Lactobacillus reuteri in Its Biofilm State Improves Protection from Experimental Necrotizing Enterocolitis. Nutrients, 13.","DOI":"10.3390\/nu13030918"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jones, S.E., and Versalovic, J. (2009). Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors. BMC Microbiol., 9.","DOI":"10.1186\/1471-2180-9-35"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2672.1995.tb03164.x","article-title":"In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria","volume":"79","author":"Midolo","year":"1995","journal-title":"J. Appl. Bacteriol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1574-695X.2002.tb00541.x","article-title":"Inhibition of binding of Helicobacter pylorito the glycolipid receptors by probiotic Lactobacillus reuteri","volume":"32","author":"Mukai","year":"2002","journal-title":"FEMS Immunol. Med Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1099\/jmm.0.061135-0","article-title":"Analysis of the microbial ecology between Helicobacter pylori and the gastric microbiota of Mongolian gerbils","volume":"63","author":"Zaman","year":"2014","journal-title":"J. Med. Microbiol."},{"key":"ref_25","first-page":"S88","article-title":"Helicobacter pylori eradication with Lactobacillus reuteri. A double blind placebo-controlled study","volume":"37","author":"Saggioro","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.11150\/kansenshogakuzasshi1970.81.387","article-title":"Lactobacillus reuteri Tablets Suppress Helicobacter pylori Infection","volume":"81","author":"Imase","year":"2007","journal-title":"Kansenshogaku Zasshi"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1523-5378.2008.00593.x","article-title":"Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: A pilot study","volume":"13","author":"Francavilla","year":"2008","journal-title":"Helicobacter"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11739-013-1013-z","article-title":"Lactobacillus reuteri in the treatment of Helicobacter pylori infection","volume":"9","author":"Dore","year":"2014","journal-title":"Intern. Emerg. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3409820","DOI":"10.1155\/2019\/3409820","article-title":"Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus\u00ae) and a Proton-Pump Inhibitor","volume":"2019","author":"Dore","year":"2019","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_30","first-page":"251","article-title":"Triple therapies plus different probiotics for Helicobacter pylori eradication","volume":"12","author":"Scaccianoce","year":"2008","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1365-2036.2006.03145.x","article-title":"Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: A randomized placebo controlled trial","volume":"24","author":"Lionetti","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"740381","DOI":"10.1155\/2012\/740381","article-title":"Impact of Lactobacillus reuteriSupplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy","volume":"2012","author":"Ojetti","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.3748\/wjg.v18.i43.6250","article-title":"Helicobacter pylori eradication: Sequential therapy and Lactobacillus reuteri supplementation","volume":"18","author":"Efrati","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MCG.0000000000000007","article-title":"Lactobacillus reuteri Strain Combination In Helicobacter pylori Infection","volume":"48","author":"Francavilla","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1756283X13503514","article-title":"Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: A double-blind placebo-controlled randomized clinical trial","volume":"7","author":"Emara","year":"2014","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_36","first-page":"e3411","article-title":"Inclusion of Lactobacillus Reuteri in the Treatment of Helicobacter pylori in Sardinian Patients","volume":"95","author":"Dore","year":"2016","journal-title":"Medicina"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e12659","DOI":"10.1111\/hel.12659","article-title":"Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera\u00ae or L a ctobacillus reuteri for treatment na\u00efve or for retreatment of Helicobacter pylori. Two randomized pilot studies","volume":"24","author":"Dore","year":"2019","journal-title":"Helicobacter"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.31557\/APJCP.2019.20.9.2859","article-title":"High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study","volume":"20","author":"Poonyam","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"M\u00e1rquez, C.M., \u00c1lvarez, P.F., Delgado, T.V., Laria, L.C., Arias, F.A., \u00c1lvarez, A.C., and Rodr\u00edguez, B.J.G. (2021). Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori. Rev. Espa\u00f1ola Enferm. Dig.","DOI":"10.17235\/reed.2021.7931\/2021"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.3390\/nu5083062","article-title":"Non-Viable Lactobacillus reuteri DSMZ 17648 (Pylopass\u2122) as a New Approach to Helicobacter pylori Control in Humans","volume":"5","author":"Mehling","year":"2013","journal-title":"Nutrients"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12602-014-9181-3","article-title":"Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study","volume":"7","author":"Holz","year":"2015","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_42","first-page":"352","article-title":"Lactobacillus reuteri versus triple therapy for the eradication of Helicobacter pylori in functional dyspepsia","volume":"92","author":"Muresan","year":"2019","journal-title":"Med. Pharm. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40795-018-0257-4","article-title":"The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: A placebo-controlled, single-blind study","volume":"4","author":"Buckley","year":"2018","journal-title":"BMC Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e15180","DOI":"10.1097\/MD.0000000000015180","article-title":"Efficacy and safety of probiotics in eradicating Helicobacter pylori","volume":"98","author":"Shi","year":"2019","journal-title":"Medicine"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Yu, M., Zhang, R., Ni, P., Chen, S., and Duan, G. (2019). Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223309"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41575-019-0199-6","article-title":"Author Correction: Probiotics and prebiotics in intestinal health and disease: From biology to the clinic","volume":"16","author":"Sanders","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00228-017-2291-6","article-title":"Efficacy and safety of probiotic-supplemented triple therapy for eradication of Helicobacter pylori in children: A systematic review and network meta-analysis","volume":"73","author":"Feng","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"L\u00fc, M., Yu, S., Deng, J., Yan, Q., Yang, C., Xia, G., and Zhou, X. (2016). Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0163743"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/7\/733\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:32:15Z","timestamp":1760164335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/7\/733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["medicina57070733"],"URL":"https:\/\/doi.org\/10.3390\/medicina57070733","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]}}}